CING may be getting ready CING is resting on 50 EMA, and on a key level.
It is also flashing 'bottom in' on CM WilliamsVixFix indicator and it has a healthy RSI.
CING trade ideas
$CING Cingulate Inc Target PT 33 and higherNASDAQ:CING Cingulate Inc
Target PT 33 and higher
Cingulate Inc., a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders intended for children, adolescents, and adults. It also focuses on developing CTx-2103 for the treatment of anxiety disorders. The company was founded in 2012 and is headquartered in Kansas City, Kansas.
$CING - Cingulate ADHD 1 Dose Medicine, MICRO FLOAT, ROCKET SHIP937K shares, 2.2M marketcap micro float. ADHD 1 dose medicine advancing through trials with FDA guidance. I wouldn't be surprised to see NASDAQ:ARCT , NASDAQ:DRRX , or NASDAQ:NLSP buy them up! Do your own due diligence. Do not take this as financial advice. I own shares in this company.
$CING - LOW FLOAT + CAP - 1 Pill for ADHD/ANXIETY (ROCKETSHIP?)They announced positive top line results from their P3 trial. Adolescent and paediatric trials are happening both this month and next. Major competitors such as NYSE:JNJ , NYSE:PFE , NYSE:NVS that require multiple pills a day for the same effect. Extremely large TAM. Buyout candidate? We have popped off of the bottom channel and are looking for 1.10. A breakout above that sends it to 1.40-1.50 range. This is my own opinion and shouldn't be taken as financial advice. Own your trades.
$CING - Low Float - Positive Top Line Results - ADHD 1 PILLWe are traveling the bottom of the channel. I think it starts to move up shortly. Adolescent and Pediatric fixed dose phase 3 trials start this month and next month. FDA approval submission early/mid next year. Billion-dollar drug if it can get some funding? This is my own opinion, and you should not take any of this as financial advice.
